Literature DB >> 17492507

Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins.

Rui Tian1, Li-Ming Wei, Ren-Yi Qin, Yan Li, Zhi-Yong Du, Wei Xia, Cheng-Jian Shi, Hong Jin.   

Abstract

A comparative proteomic approach has been used to identify and analyze proteins related to pancreatic cancer. Proteomes of eight pairs of clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples and samples of normal adjacent tissue were obtained by two-dimensional gel electrophoresis (2DE). Comprehensive analysis of proteins was focused on total protein spots for which there were statistical differences between the two groups. Proteins were identified by peptide mass fingerprinting with tandem mass spectrometry (MS-MS). Western blotting and immunohistochemistry (IHC) were also performed to verify the expression of some candidate proteins. Thirty protein spots were identified, including proteases, antioxidant proteins, signal-transduction proteins, calcium-binding proteins, structural proteins, chaperones, and others. Western blotting and IHC confirmed up-regulated expression of two candidate proteins, nucleotide diphosphatase kinase (NDPK) and annexin II, in tumorous tissues. These results suggest that combination of 2DE with MS is an effective strategy for discovery of differently expressed proteins in PDAC which may be molecular markers for diagnosis or therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492507     DOI: 10.1007/s10620-007-9823-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

Review 1.  Early detection of pancreatic carcinoma.

Authors:  Christophe Rosty; Michael Goggins
Journal:  Hematol Oncol Clin North Am       Date:  2002-02       Impact factor: 3.722

Review 2.  Annexins and disease.

Authors:  Matthew J Hayes; Stephen E Moss
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

Review 3.  Proteomic technologies and their application to pancreatic cancer.

Authors:  Dale Vimalachandran; Eithne Costello
Journal:  Expert Rev Proteomics       Date:  2004-12       Impact factor: 3.940

4.  Knockdown of annexin 2 decreases migration of human glioma cells in vitro.

Authors:  L Tatenhorst; U Rescher; V Gerke; W Paulus
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

5.  Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.

Authors:  Ju-Tao Feng; Yin-Kun Liu; Hai-Yan Song; Zhi Dai; Lun-Xiu Qin; Mohamad Radwan Almofti; Cai-Yun Fang; Hao-Jie Lu; Peng-Yuan Yang; Zhao-You Tang
Journal:  Proteomics       Date:  2005-11       Impact factor: 3.984

6.  Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.

Authors:  I Esposito; R Penzel; M Chaib-Harrireche; U Barcena; F Bergmann; S Riedl; H Kayed; N Giese; J Kleeff; H Friess; P Schirmacher
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

7.  Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.

Authors:  H Friess; X Z Guo; A A Tempia-Caliera; A Fukuda; M E Martignoni; A Zimmermann; M Korc; M W Büchler
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

8.  Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.

Authors:  Ahmed Guweidhi; Jörg Kleeff; Nathalia Giese; Jamael El Fitori; Knut Ketterer; Thomas Giese; Markus W Büchler; Murray Korc; Helmut Friess
Journal:  Carcinogenesis       Date:  2004-04-08       Impact factor: 4.944

9.  Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.

Authors:  Jee-Eun Kim; Kyu Taek Lee; Jong Kyun Lee; Seung Woon Paik; Jong Chul Rhee; Kyoo Wan Choi
Journal:  J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 4.029

10.  Peroxiredoxins, a novel protein family in lung cancer.

Authors:  Siri T Lehtonen; Anne-Mari Svensk; Ylermi Soini; Paavo Pääkkö; Pasi Hirvikoski; Sang Won Kang; Marjaana Säily; Vuokko L Kinnula
Journal:  Int J Cancer       Date:  2004-09-10       Impact factor: 7.396

View more
  9 in total

1.  Proteomics of rat prostate lobes treated with 2-N-hydroxylamino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 5alpha-dihydrotestosterone, individually and in combination.

Authors:  Telih Boyiri; Richard I Somiari; Stephen Russell; Cesar Aliaga; Karam El-Bayoumy
Journal:  Int J Oncol       Date:  2009-09       Impact factor: 5.650

Review 2.  Current status of molecular markers for early detection of sporadic pancreatic cancer.

Authors:  Subhankar Chakraborty; Michael J Baine; Aaron R Sasson; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2010-10-01

3.  The association of annexin A2 and cancers.

Authors:  Xiaohui Zhang; Shuqing Liu; Chunmei Guo; Junwei Zong; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

4.  A functional proteomic method for biomarker discovery.

Authors:  Fred Reynolds; Nivedha Panneer; Christopher M Tutino; Michael Wu; William R Skrabal; Christopher Moskaluk; Kimberly A Kelly
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

5.  Proteomic analysis of INS-1 rat insulinoma cells: ER stress effects and the protective role of exenatide, a GLP-1 receptor agonist.

Authors:  Mi-Kyung Kim; Jin-Hwan Cho; Jae-Jin Lee; Moon-Ho Son; Kong-Joo Lee
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Annexin A2 heterotetramer: structure and function.

Authors:  Alamelu Bharadwaj; Moamen Bydoun; Ryan Holloway; David Waisman
Journal:  Int J Mol Sci       Date:  2013-03-19       Impact factor: 5.923

Review 7.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

8.  Screening technologies for target identification in pancreatic cancer.

Authors:  Patrick Michl; Stefanie Ripka; Thomas Gress; Malte Buchholz
Journal:  Cancers (Basel)       Date:  2010-12-29       Impact factor: 6.639

9.  Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.

Authors:  Kung-Kai Kuo; Chao-Jen Kuo; Chiang-Yen Chiu; Shih-Shin Liang; Chun-Hao Huang; Shu-Wen Chi; Kun-Bow Tsai; Chiao-Yun Chen; Edward Hsi; Kuang-Hung Cheng; Shyh-Horng Chiou
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.